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Abstract 
Osteoporosis is a disease characterized by low bone mass, leading to an increased risk of fragility 
fractures. GATA4 is a zinc-finger transcription factor that is important in several tissues, such as 
the heart and intestines, and has recently been shown to be a pioneer factor for estrogen receptor 
alpha (ER) in osteoblast-like cells. Herein, we demonstrate that GATA4 is necessary for 
estrogen-mediated transcription and estrogen-independent mineralization in vitro. In vivo 
deletion of GATA4, driven by Cre-recombinase in osteoblasts, results in perinatal lethality, 
decreased trabecular bone properties and abnormal bone development. Microarray analysis 
revealed GATA4 suppression of TGF signaling, necessary for osteoblast progenitor 
maintenance and concomitant activation of BMP signaling, necessary for mineralization. Indeed, 
pSMAD1/5/8 signaling, downstream of BMP signaling, is decreased in the trabecular region of 
conditional knockout femurs, and pSMAD2/3, downstream of TGF signaling, is increased in 
the same region. Together these experiments demonstrate the necessity of GATA4 in osteoblasts. 
Understanding the role of GATA4 to regulate the tissue specificity of estrogen-mediated 
osteoblast gene regulation and estrogen-independent bone differentiation may help to develop 
therapies for post-menopausal osteoporosis.  
 
Key words: 
GATA4; Estrogen; TGF beta, BMP, Osteoblast 
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Introduction 
One out of 2 women over the age of 50 will experience an osteoporotic fracture in her 
lifetime (1). The highest risk factor for osteoporosis is being post-menopausal. Thus, 
understanding the mechanism of action of estrogens in bone is key to preventing and treating 
osteoporosis. 17-estradiol (E2) induces apoptosis in bone resorbing osteoclasts and is anti-
apoptotic in osteoblasts, leading to an overall building of bone (2). Towards this end, we showed 
that E2, via estrogen receptor alpha (ER), induces transcription of Fas Ligand (FasL) in 
osteoblasts resulting in a paracrine signal to induce osteoclast apoptosis (3). E2 also induces 
transcription of alkaline phosphatase and Bmp2 in osteoblasts, thereby regulating osteoblast 
differentiation (4).  
The GATA family of transcription factors is a conserved set of proteins that bind to the 
DNA sequence (A/T)GATA(A/G). Gata4 is expressed early in embryogenesis and is a key 
regulator of mesodermal and endodermal development (5). Gata4 was recently described to be 
expressed in osteoblasts, and to be regulated by ER (6). However, a role for GATA4 in the 
commitment of bone progenitors, differentiation of pre-osteoblasts, or mineralization of bone has 
not been previously described. 
TGF and BMP family members play important roles in skeletal development (7). 
TGF-1, -2 and -3 are important in the maintenance and expansion of osteoblast progenitors, and 
BMP-2, -4, -5, -6 and -7 induce osteoblast differentiation (8). TGF signaling leads to the 
phosphorylation of SMAD2/3, which then stimulates proliferation and early osteoblast 
differentiation, while inhibiting terminal differentiation (9). BMP signaling leads to the 
phosphorylation of SMAD1/5/8 and activation of the expression and activity of Runx2 and other 
genes (7) necessary for osteoblast differentiation. Although the actions of both TGF and BMP 
A
cc
ep
te
d 
A
rt
ic
le
  
Page 4 
signaling in bone have been fairly well characterized, the mechanisms regulating their 
transcriptional regulation are poorly understood.  
GATA4 and SMAD signaling pathways regulate transcription in the heart, gut, and 
ovaries. In heart development, BMP4 signaling regulates Gata4 expression (10) and conversely 
GATA4 regulates Bmp4 expression (11). Furthermore, GATA4 and SMADs co-activate 
transcription of heart specific genes such as Nkx2-5 (12). GATA4 and TGF signaling crosstalk 
in the gut, where they synergize to regulate epithelial gene expression (13); similarly, in 
granulosa cells of the ovary, TGF upregulates Gata4 and then GATA4 and SMAD3 cooperate 
to regulate inhibin-alpha (14).  
Global knockout of Gata4 in the mouse reveals heart and gut defects and lethality 
between embryonic days 7.5 and 10.5 (15, 16). Due to the early embryonic lethality of these 
models, the importance of GATA4 for bone development in vivo was never studied. In order to 
investigate osteoblast-specific effects of GATA4, we analyzed the estrogen-dependent and -
independent effects of GATA4 in vitro, and then selectively ablated GATA4 in osteoblasts in 
vivo. These results show that GATA4 in osteoblasts is necessary for survival and proper bone 
development. Furthermore, we demonstrate that GATA4 regulates TGF and BMP pathways in 
osteoblasts. Together, these studies identify GATA4 as a regulator of osteoblast commitment 
during early development via E2-dependent and -independent pathways. 
 
Materials and Methods 
Ethics Statement 
All animal work was approved by the Animal Research Committee at UCLA. 
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Reagents 
17β-estradiol (E2) was purchased from Sigma-Aldrich Co. All E2 experiments were performed 
in media without phenol red and with 5% charcoal dextran-treated fetal bovine serum (CDT-
FBS) (Omega Scientific). The following antibodies were used: ER (Thermo Fisher Scientific, 
clone Ab-16), GATA4 (Santa Cruz, Clone G4), RUNX2 (R&D Systems), and -actin (Sigma-
Aldrich Co.). SMAD antibodies were obtained from Cell Signaling (pSmad1/5/8 #9511, 
pSmad2: #3108, Smad2:  #3122, Smad3: #9523, Smad5: #9517). 
 
Mice 
Gata4 flox/flox mice were purchased from Jackson Labs (Gata4tm1.1Sad/J) and backcrossed for 
10 generations to the FVB background. Col1A1 (2.3 kb)-Cre mice (FVB-Tg(Col1a1-
cre)1Kry/Mmucd) were purchased from the Mutant Mouse Regional Resource Centers 
(MMRRC). 
 
Primary calvarial osteoblasts 
Neonatal CD1 calvaria were obtained two days after birth and incubated for 40 minutes in 
MEM-1.0 mg/ml collagenase P-1.25% trypsin at 37°C. These were washed in MEM, and 
transferred to MEM-1.0 mg/ml collagenase P-1.25% trypsin for 1 hour at 37°C(17). Digestion 
was stopped by addition of MEM/10% FBS. The cells from the second digest were allowed to 
attach for 48 hours and then differentiated in mineralization medium with media replacement 
every three days. Differentiation was confirmed by quantitation of col1A1, bone sialoprotein 
(BSP) and osteocalcin mRNA, alkaline phosphatase positivity, and alizarin red staining for 
mineralization. 
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Pericytes 
Perivascular cells (pericytes) were obtained from human abdominal subcutaneous fat or 
lipoaspirate, fetal lung, fetal muscle, or fetal bone marrow as described (18). Since specimens 
were obtained as anonymous and unidentifiable, the activities of the present research do not 
involve human subjects and therefore do not require IRB review according to UCLA IRB 
medical committee standards. For in vitro mineralization, cells were differentiated with the 
HyClone AdvanceSTEM Osteogenic Differentiation Kit (Fisher Scientific). 
 
Lentiviral silencing 
For shRNA-mediated knockdown of Gata4 expression, cells were plated in six-well plates (1 X 
10
5
 cells per well) and infected 24 hours later with lentivirus. Cells were treated with virus in 2 
mL MEM per well with a final concentration of 8 g/mL Polybrene. Plates were centrifuged at 
1400 X g at 30°C for 45 minutes. The following day the media was replaced with mineralization 
medium with media replacement every three days. Knockdown of Gata4 was confirmed by 
qPCR and immunoblotting. Two different shRNA from The RNAi Consortium (TRC) in pLKO 
vector were used to knockdown mouse Gata4 (TRCN0000095215: 
CCGGCCCAATCTCGATATGTTTGATCTCGAGATCAAACATATCGAGATTGGGTTTTT
G and TRCN0000095217: 
CCGGCATCTCCTGTCACTCAGACATCTCGAGATGTCTGAGTGACAGGAGATGTTTTT
G) and human GATA4 (TRCN0000020424: 
CCGGCCAGAGATTCTGCAACACGAACTCGAGTTCGTGTTGCAGAATCTCTGGTTTTT 
and TRCN0000020428: 
CCGGCCCGGCTTACATGGCCGACGTCTCGAGACGTCGGCCATGTAAGCCGGGTTTTT
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). pLKO-shGFP was used as a negative control for mouse experiments and pLKO-C (shC, with 
no mammalian target) was used for human experiments. 
 
RNA and Quantitative PCR (qPCR) 
Cells were hormone-deprived by culture for three days in phenol red-free medium (Invitrogen 
Corporation) supplemented with 5% CDT-FBS. Cells were treated with 10 nM E2 or ethanol as a 
vehicle control for 3 or 24 hours. Total RNA was converted to cDNA with Superscript III First 
Strand Synthesis Kit according to the manufacturer’s instructions (Invitrogen Corporation). 
Primers were selected using Primer3 (19) and the sequences are listed in Supplemental Fig. 10. 
cDNA was subjected to quantitative PCR using SYBR Green Mastermix with ROX. Each RNA 
sample was collected in triplicate and each PCR reaction was amplified in triplicate. 
 
Microarray 
Total RNA was analyzed using the MouseRef-8 v2.0 Expression BeadChips from Illumina. Data 
was analyzed using GenomeStudio (Illumina). Gene ontology was performed by The Database 
for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 (20). Upon acceptance, 
microarray data will be submitted to NCBI Geo Database. 
 
Immunohistochemistry 
Formalin-fixed paraffin-embedded samples were processed through standard deparafinization 
protocols. The tissue was then incubated in blocking buffer (5% normal goat serum, 2.5% BSA 
in PBS at pH 7.5) for 30 min. Primary antibodies were incubated overnight at 4°C in a 
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humidified chamber followed by either the DAKO Envision+ visualization system and 
counterstaining with Hematoxylin or by immunofluorescence with DAPI counterstaining. 
 
Protein and Immunoblotting 
Cells were hormone-deprived by culture for three days in phenol red-free medium (Invitrogen 
Corporation) supplemented with 5% CDT-FBS. Cells were treated with 10 nM E2 or ethanol as a 
vehicle control for 24 hours and then lysed in EBC buffer (50 mM Tris, pH 8, 120 mM NaCl, 
0.5% Nonidet P-40) supplemented with a protease inhibitor mixture (Complete, Roche Applied 
Science) for 30 min on ice. Proteins were subjected to SDS-PAGE and immunoblotting with 
antisera to the indicated proteins.  
 
Alkaline Phosphatase Assay 
Osteoblasts were differentiated for the indicated amount of time and then fixed with 3.7% 
formaldehyde, and stained for alkaline phosphatase activity with SigmaFast BCIP/NBT (Sigma). 
 
Mineralization Assay 
Osteoblasts were fixed in 50% ethanol for 15 minutes at 4°C. 1% Alizarin Red S (w/v with 0.1% 
ammonium hydroxide) was added for 30 minutes. The stain was washed with water and 
photographed. The alizarin red was eluted with 10% cetylpyridinium chloride and the OD was 
measured at 570 nm. 
 
RNA in situ 
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Gata4 mRNA was detected by RNAscope technology (2.0 High Definition, Advanced Cell 
Diagnostics) in wildtype FVB embryos according to the manufacturer’s recommendations. 
 
Recombination Efficiency 
The calvariae of P0 mice were placed on a stainless steel grid in a 12-well tissue culture dish in 
differentiation media for 7 days. RNA from calvariae was obtained and cDNA was synthesized. 
Primers were designed to anneal to WT cDNA in exon 5 (which is excised by Cre recombinase) 
and exon 6 of Gata4 (GCGGAAGGAGGGGATTCAAA and TGAATGTCTGGGACATGGAGC).  
 
Skeletal Preparations 
Skeletal preparations were performed as in (21). Briefly, embryos were eviscerated and fixed in 
95% EtOH overnight at 4°C, followed by Alcian Blue staining (0.01% Alcian Blue 8GX [Sigma-
Aldrich] [w/v] in 95% EtOH) overnight at room temperature. Samples were then stained for 
Alizarin Red (0.05% Alizarin Red S [Sigma-Aldrich] [w/v] in 1% KOH) for 3 to 4 hours and 
cleared in a series of graded KOH in glycerol. 
 
Von Kossa 
Deparaffinized sections were incubated with 1% silver nitrate solution under ultraviolet light for 
30 minutes. Unreacted silver was removed with 5% sodium thiosulfate. The sections were 
counterstained with nuclear fast red. 
 
Bone MicroCT Scanning and Analysis 
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Femurs, tibia/fibula, L5 vertebrae, and skulls from a total of 9 P0 WT and Gata4 cKO mice were 
dissected, cleaned of soft tissue, and stored in 70% ethanol before CT scanning. MicroCT 
scanning was performed with a Skyscan 1172 scanner (Skyscan, Kontich, Belgium) with the X-
ray energy equaling 30 KVp and 175 μA and a voxel isotropic resolution of 6 μm. Prior to 
scanning, bones were positioned with gauze in the sample holder. To compare femur 
measurements of trabecular bone microarchitecture and cortical bone morphology, 65 transaxial 
slices were reconstructed and measured for each sample covering 370 μm of the distal 
metaphysis starting 0.290 mm above the distal epiphysis and moving along the shaft, and 66 
slices covering 380 μm (33 slices each above and below the mid-diaphysis), respectively. For 
trabecular bone measurements contours were drawn in the medullar cavity at a fixed distance 
from the endosteum to define tissue volume. For L5 vertebrae, 60 slices, covering ~345 μm, 
were analyzed. Bone volume fraction (BV/TV), trabecular number (Tb.N.), trabecular thickness 
(Tb.Th.) and trabecular separation (Tb.Sp.) were measured for L5 vertebrae and trabecular bone 
of the femur utilizing the CTAn software (Skyscan, Kontich, Belgium). For cortical bone 
measurements contours were drawn immediately adjacent to the periosteum bone perimeter to 
define the periosteal envelope. Total cross sectional area (T.Ar.), cortical bone area (B.Ar.), 
cortical area fraction (% B.Ar.), and mean cortical thickness (Ct.Th.) were measured utilizing the 
CTAn software (Skyscan, Kontich, Belgium).  
 
Statistical Analysis 
All experiments represent both biological and experimental triplicates. Error bars represent mean 
+/- 1 standard deviation (S.D.). ** = p value < 0.01. * = p value < 0.05 using an Student’s t test. 
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Results 
GATA4 regulates ER and ER target genes in osteoblasts 
Maximal binding of GATA4 to osteoblast-specific target gene enhancers precedes ER 
binding, and GATA4 is necessary for open chromatin (marked by histone 3 lysine 4 
dimethylation) at ER binding sites. In accordance, knockdown of GATA4 led to a reduction of 
ER binding to DNA at these sites. Together, these results suggest that GATA4 is a pioneer 
factor (pioneer factors are a special class of transcription factor that can associate with 
compacted chromatin to facilitate the binding of additional transcription factors (22)) for ER in 
osteoblast-like cells (6). Therefore, we performed knockdown of Gata4 in primary murine 
calvarial osteoblasts to determine the effects of GATA4 on ER and ER target gene regulation. 
Gata4 can be successfully knocked down with lentivirally expressed short hairpins directed at 
Gata4 mRNA. Two different short hairpins (designated #2 and #4) reduced the level of Gata4 
mRNA by more than two-thirds (Fig. S1A) compared to shGFP-infected cells. For consistency, 
all figures show shGATA4 #2 and supplemental figures show shGATA4 #4. ShGATA4 
lentivirus induced apoptosis in 5.8% of the cells (Fig. S2) compared to 0% of the shGFP infected 
cells. However, after two weeks of differentiation, both the shGATA4 and shGFP infected cells 
were at confluence (data not shown). In vehicle (ethanol, EtOH)-treated cells, shGATA4 reduced 
the basal levels of ER mRNA and protein (Fig. 1A and 1B). Additionally, shGATA4 affected 
the E2 response of ER in these cells. ER protein and mRNA levels are negatively regulated 
following E2 treatment in E2-treated shGFP calvarial osteoblasts, as observed previously in 
other cell types (23, 24). Loss of GATA4 in primary calvarial osteoblasts treated with E2 led to 
an increase in ER mRNA and protein compared to vehicle treated cells (Fig. 1A and 1B). 
Together, this data demonstrate a mis-regulation of ER signaling in GATA4 ablated cells.  
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FasL and alkaline phosphatase are two important targets of ER in osteoblasts (3, 
25) (Fig. 1C and 1D). When GATA4 is knocked-down, E2 can no longer induce FasL and 
alkaline phosphatase mRNA (Fig. 1C and 1D), suggesting that GATA4 protein is necessary 
for expression of E2-mediated gene targets in primary calvarial osteoblasts. E2 also 
increases Gata4 mRNA, and after shGATA4, Gata4 mRNA is not increased (Fig. S1B). 
Therefore, GATA4 is necessary to regulate E2 targets in primary osteoblasts, regulating 
both osteoblast differentiation (via alkaline phosphatase) and osteoclast apoptosis (via 
FasL). 
ER-independent roles for GATA4 in bone mineralization 
 Because GATA4 regulates osteoblast differentiation genes such as alkaline phosphatase 
(Fig. 1D), we hypothesized that GATA4 may be necessary for proper differentiation and 
mineralization. To test this, primary calvarial osteoblasts were differentiated for 14 days 
following Gata4 knockdown and alkaline phosphatase activity and mineralization were 
quantitated (Fig. 2A-B). Knockdown of Gata4 reduced the amount of alkaline phosphatase 
activity as early as 3 days after differentiation and throughout the time course of differentiation  
(Fig. 2A). Furthermore, knockdown of Gata4 led to a greater than 2-fold reduction in 
mineralization, as compared to control shGFP (p  < 0.001, Fig. 2B). An independent shRNA 
targeting of Gata4 (shGATA4 #4) confirmed a significant reduction in mineralization (Fig. S3). 
The data suggest an essential role for GATA4 in differentiation and/or mineralization in primary 
osteoblasts. Interestingly, E2 does not increase mineralization in calvarial osteoblast cultures in 
vitro (data not shown and (26)). In addition, E2 treatment does not increase expression of bone 
differentiation markers such as bone sialoprotein (BSP (Spp1)), osteocalcin (OCN (Bglap)), 
Col1A1, or RUNX2 (Fig. 2C-F). However, knockdown of Gata4 significantly reduced the levels 
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of BSP, OCN, Col1A1 and RUNX2 mRNA, corresponding with the differentiation and 
mineralization assays, indicating E2-independent effects for GATA4 in osteoblast differentiation.   
 
GATA4 is necessary in mesenchymal stem cells for osteoblast differentiation 
The expression of Gata4 during osteoblast differentiation was further investigated in 
order to determine if GATA4 has stage-specific effects on osteoblast formation and/or activity. 
Gata4 mRNA is reduced by five-fold after one day of osteoblast differentiation, and by more 
than 10-fold after 16 days of differentiation (Fig. 3A). However, mature osteoblasts still express 
significantly more Gata4 mRNA than mammary gland cells utilized as the control tissue for the 
absence of Gata4 expression. This suggests that GATA4 might influence early stage “precursor” 
decisions upstream of mature terminally differentiated osteoblast cells. We next verified that 
Gata4 is expressed more highly in human mesenchymal stem cells than in differentiated 
osteoblasts to assess the translational potential of the model. Human fat adventitial cells, fetal 
lung pericytes, fetal muscle pericytes and fetal bone marrow pericytes (the native ancestors of 
mesenchymal stem cells) were left undifferentiated or differentiated into osteoblasts (18). Gata4 
mRNA was significantly lower in terminally differentiated osteoblasts than in undifferentiated 
cells (Fig. 3B-C). There is an inverse relationship between osteoblast differentiation markers 
(Col1A1 and alkaline phosphatase mRNA) and Gata4 mRNA expression (Fig. 3C). Therefore, 
Gata4 is expressed more highly in mesenchymal stem-like cells than in differentiated, 
mineralizing osteoblasts.  
 The observation that Gata4 expression is higher prior to differentiation raises the 
possibility that GATA4 plays a critical role at the phase of osteoblast commitment. To test this, 
Gata4 was either knocked down “early” (in undifferentiated pericytes), or “late” in 
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differentiating osteoblasts (1 week after initiating differentiation, Fig. 3D). The corresponding 
alkaline phosphatase levels, indicating the amount of differentiation of wildtype pericytes, is 
demonstrated in Fig. 3E. The cells were selected with puromycin to ensure efficient lentiviral 
infection, and then induced to mineralize. Cells infected with control lentivirus showed efficient 
mineralization, as visualized by alizarin red staining, whether infected early or late (Fig. 3F-G). 
In contrast, cells infected with shGATA4 before differentiation exhibited a significant reduction 
in the amount of mineralization compared to control infected cells. However, osteoblasts infected 
with shGATA4 “late” in differentiation showed no loss of mineralization, suggesting that 
GATA4 plays a role in either osteoblast progenitors or early in differentiation. Taken together, 
the above results suggest that in vitro in both human and mouse osteoblasts, GATA4 elicits its 
strongest effects on “early” progenitor and/or precursor cells.  
 
GATA4 expression in vivo 
 GATA4 has been described in detail in the developing heart, intestines and several other 
tissues (5). Indeed, analysis of Gata4 mRNA in E18.5 embryos reveal highest expression in 
these tissues (Fig. S4, and data not shown). However, based on the in vitro data described above, 
Gata4 expression was analyzed in the developing skull and hind limb. Gata4 mRNA is abundant 
in the ventricular zone of the developing brain in E13.5, E14.5, and E16.5 mice, before 
ossification of the skull utilizing highly sensitive in situ RNA hybridization (RNAscope 
technology) (Fig. 4). At E18.5 Gata4 mRNA has decreased significantly in the brain and is 
present near and/or within the ossifying skull. Gata4 mRNA is also present in proliferating 
chondrocytes in E13.5, E14.5, and E16.5 hind limbs, which has not been previously reported. At 
E18.5 Gata4 mRNA is expressed at the ossification front of the growth plate and periosteum. 
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While the precise identity of the Gata4-positive cells in these locations is as yet unclear, the data 
are consistent with a direct role for GATA4 at various times and stages in normal embryonic 
bone development. 
 
GATA4 is necessary for bone development in embryogenesis in vivo 
 To determine the role of GATA4 in vivo, Gata4 floxed (GATA4Fl/Fl) mice were crossed 
with mice expressing Cre recombinase under control of a 2.3 kb fragment of the rat Col1a1 gene 
(27). Previous studies have shown that Cre-mediated deletion of exons 3, 4 and 5 of the Gata4 
gene converts the floxed allele into a recombined allele no longer capable of encoding a 
functional GATA4 protein (28). Gata4 recombination efficiency in osteoblasts was determined 
in vivo by qPCR of mRNA, using primers that cannot detect recombined Gata4 mRNA. Gata4 
mRNA was reduced by over 75% in differentiated calvarial organs of GATA4Fl/FlCre+ mice 
(conditional knockout, cKO) (Fig. 5A). The actual recombination of Gata4 in osteoblasts is 
probably significantly higher, since the calvarial organs consist of other cell types, such as 
stromal cells. 
Gata4 cKO mice were not present at Mendelian ratios after embryonic day 16.5 (Fig. 5B). 
Mutants were morphologically indistinguishable from control littermates’ appearance at any age, 
including E18.5 (Fig. 5C) or P1 (Fig. 5D), or by weight (Fig. 5E). The mice did not exhibit any 
obvious heart defects, as might be predicted from leaky Col1a1-Cre expression. Whole hearts 
and H&E stained sections of left and right ventricles from P0 animals revealed normal septal 
structure, and a well-developed myocardium (Fig. S5 and data not shown). In addition, heart 
weight-to-body weight ratios were the same in wildtype and cKO littermate animals (Fig. S5). 
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Thus, while we cannot at present determine the cause of death of cKO mice, we have no 
evidence that heart defects are responsible.  
 Skeletal preparations of E18.5 mice revealed no gross abnormalities (Fig. 6A-B). 
However, closer examination revealed multiple skull defects (Fig. 6C-J and S5), including 
smaller zygomatic bones (Fig. 6C-D, red arrows), a more mineralized occipital one (Fig. 6D and 
6F) and decreased thickness of cranial bone (Fig. 6G-H, red lines). Furthermore, Von Kossa 
staining and microCT analysis demonstrate a reduced mineralization of the skull in the cKO 
mice (Fig. 6I-J, Fig. S5F-G).  
In addition to cranial defects, we also observed vertebral and appendicular defects. 
Individual lumbar vertebrae were larger and misshapen (Fig. 6K-L), leading to an overall 
increase in spine length of cKO mice (Fig. 6M). The vertebral bodies of the cKO mice have a 
decrease in hypertrophic chondrocytes (Fig 6N-O) and irregular mineralization (Fig. 6P-Q). 
There is a lack of fusion of the distal tibia and fibula in cKO mice as observed by both skeletal 
preparations (Fig. 6R-S) and microCT (Fig. 6T-U). There is also a decrease in hypertrophic 
chondrocytes and mineralization in the femurs of cKO mice (Fig. 6V-Y). 
To quantify the mineralization effects in Figure 6, microCT analysis was performed on 
the femurs and vertebrae of WT and cKO newborn mice, which demonstrated that cKO mice had 
reduced trabecular bone (Fig. 7A-L). The trabecular bone volume (BV/TV), trabecular number 
(Tb.N.) and trabecular thickness (Tb.Th.) were significantly reduced in cKO femurs compared to 
wildtype littermates (Fig. 7C-E). Trabecular spacing was increased in the cKO mice, although it 
did not reach statistical significance (Tb.Sp., Fig. 7F). Cortical bone parameters (total cross 
sectional area, cortical bone area, cortical bone area fraction or cortical thickness) were not 
statistically different between wildtype and cKO littermate animals (Fig. S7). MicroCT analysis 
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of lumbar vertebrae (L5) confirmed the irregular shape of cKO vertebrae (Fig. 7G-H) and 
revealed a significant reduction in the trabecular bone volume (BV/TV) and trabecular thickness 
(Tb.Th.) (Fig. 7I, K). Trabecular number was decreased in the cKO mice, although it did not 
reach statistical significance (Fig. 7J). Together, the skeletal preparations, histology and 
microCT analysis indicate defects in intramembranous and endochondral bone formation. 
  
GATA4 regulates TGF and BMP pathways 
 To investigate mechanisms underlying the role of GATA4 in osteoblasts, we examined 
global gene expression changes following Gata4 knockdown in primary murine calvarial 
osteoblasts (Fig. S1A). Osteoblasts were differentiated for two weeks and RNA was analyzed by 
genome-wide expression profiling (MouseRef-8 v2.0 Expression BeadChips from Illumina). 
Loss of Gata4 resulted in a decrease in expression of 1610 genes by 2 fold or greater and an 
increase in expression of 2399 genes by 2 fold or greater. Gene ontology analysis by DAVID 
software revealed several categories of differentially expressed genes. (20). The most down-
regulated genes in shGATA4 cells encode extracellular matrix proteins (p value = 3.2 X 10
-16
) 
and drive bone development (p value = 3.6 X 10
-8
), thereby confirming a role for GATA4 in 
osteoblasts. 
Loss of Gata4 resulted in mis-regulation of a large number of TGF superfamily 
pathway genes (Fig. S8-9). Key upregulated genes in this pathway were TGF2 and 3, while 
both BMP pathway genes were down-regulated. Analysis of mRNA expression in shGATA4 
infected calvarial osteoblasts confirmed decreased expression of two BMP ligands (Bmp4 and 
Bmp6), a receptor (Bmpr1A) and a downstream effector SMAD (Smad5) (Fig. 8A). Because of 
the down-regulation of BMP pathway genes, BMP pathway activation (pSMAD 1/5/8 as a 
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downstream target for BMP mediated signaling (7)) was analyzed with a phosphorylated SMAD 
(pSMAD) 1/5/8 antibody by immunoblotting. Indeed, shGATA4 cells had a reduced amount of 
pSMAD1/5/8 illustrating that BMP-mediated signal transduction has been severely attenuated. 
E2 had no effect on the regulation of pSMAD1/5/8 (Fig. 8B). Conversely, TGF2 and -3 were 
significantly upregulated in shGATA4 cells (Fig. 8C). Consistent with the upregulation of the 
ligands, pSMAD2/3 were increased in shGATA4 cells (Fig. 8D), demonstrating activation of the 
TGF pathway. E2 induced phosphorylation of SMAD2 and SMAD3 in shGFP cells, but not in 
shGATA4 cells. 
 To investigate the possibility of an in vivo role for GATA4 regulation of the TGF and 
BMP pathways, the femurs of control (Fl/Fl) and cKO mice were analyzed by IHC for 
pSMAD1/5/8 and pSMAD 2/3. cKO bones exhibited a decrease in the amount of pSMAD1/5/8 
in the trabecular bone (Fig. 8E). Conversely, pSMAD2/3 was increased in the trabecular bone 
from cKO mice, as compared to wildtype bone (Fig. 8F). Our findings thus indicate that GATA4 
is critical for the maintenance of osteoblast function, and raise the possibility that this is in part 
through regulating the balance between BMP and TGF pathway activity.  
 
Discussion 
We previously identified GATA4 as a pioneer factor for estrogen receptor in osteoblasts 
(6). Here we demonstrate that GATA4 is important for the regulation of several E2 targets in 
osteoblasts, but that GATA4 also has E2-independent functions. 
Knockout of GATA4 specifically in osteoblasts leads to embryonic and/or perinatal 
lethality. Because cKO mice were physically indistinguishable from their wild type littermates at 
all stages of development, the cause of death remains under investigation. The Col1A1 2.3 kb 
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promoter is expressed as early as E14.5, when analyzed by crossing the Col1A1-cre mouse with 
the ROSA26 reporter mouse (R26R) (29). The Col1A1-cre;R26R mouse demonstrates a high 
level of bone specific expression of Cre recombinase (29), as does mRNA from many tissues 
(27). Furthermore, the Col1a1 (2.3kb)-GFP transgene was not detected in the heart or intestines 
(30), which are two tissues with high Gata4 expression. However, it is possible that expression 
could occur at a different age, or at a level below the detection of a Northern blot. The Col1a1 
2.3kb promoter might be active in some growth plate chondrocytes (27), and the extent of this 
effect needs to be investigated. 
Although rare, Col1A1-Cre-mediated deletion has led to embryonic death (31). Crossing 
the Gata4 Fl/Fl mouse with a mouse that expresses Cre later in the osteoblast lineage, such as the 
osteocalcin promoter (32), could reveal a role for GATA4 in adult mice and potential roles in 
estrogen deficient osteoporosis. Similarly, crossing the Gata4 Fl/Fl mouse with a mouse that 
expresses Cre earlier in development could further define the “early” role for GATA4 suggested 
by the above data. 
Total Gata4 knockout mice exhibit embryonic lethality from E7.5-10.5 (15, 16), which is 
much earlier than for the osteoblast-specific knockout described here. Interestingly, specific 
knockouts of GATA4 in the heart with Cre-recombinase controlled by the β-myosin heavy 
promoter (-MHC) or -MHC promoter were generated at predicted Mendelian ratios and mice 
were viable up to 16 weeks of age (33). Gata4 deletion from the developing intestinal epithelium 
(34), pancreas (35), testicular somatic cells (36) or granulosa cells (37) also resulted in mice born 
at the expected Mendelian ratios, but with tissue-specific effects. 
These results demonstrate that GATA4 is essential for bone mineralization both in vitro 
and in vivo. MicroCT analysis shows a decrease in trabecular bone measurements in the cKO 
A
cc
ep
te
d 
A
rt
ic
le
  
Page 20 
mice. Furthermore, the skeletal preparations and microCT show defects, including those in the 
skull, legs and spine in these mice.  
Mouse models for TGF and BMP signaling in bone have been generated (reviewed in 
(8)). TGF2 overexpression leads to lower bone mineral density, in agreement with the Gata4 
cKO mice (38). TGF2-null mice have a lack of occipital bone formation (39), corresponding 
with the increase in occipital bone formation in Gata4 cKO mice and the suppression of TGF2 
by GATA4. A limb mesenchyme double knockout of both BMP2 and BMP4 (driven by the 
Prx1-cre) leads to severe bone malformation. Interestingly, the tibia and fibula in the BMP4 
knockout are not fused (40), as is seen in the Gata4 cKO. Furthermore, an osteoblast-specific 
knockout of SMAD1 leads to an osteopenic phenotype (41). Together, these mouse models are in 
agreement with a role for GATA4 in regulating TGF and BMP signaling. Genetic epistasis 
experiments will be required to test the physiological relevance of the altered BMP and TGF 
pathway activity we have observed in Gata4 cKO mice.  
GATA4 is currently being used for gene therapy in the heart in combination with heart 
specific transcription factors (42). MSCs show potential for the treatment of osteoporosis, and 
their optimization could be realized by estrogens, SERMs and/or GATA4 to better induce 
osteoblast formation. In conclusion, GATA4 in osteoblasts plays a key role in the regulation of 
TGF and BMP pathways to control bone differentiation and/or mineralization. 
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Figure Legends 
Fig 1. GATA4 regulates ER and E2 target genes. (A) Calvarial osteoblasts were infected with 
lentivirus expressing either shGFP or shGATA4. Cells were then differentiated for two weeks 
and RNA was obtained. qPCR was performed for ER and normalized to actin mRNA. (B) 
Calvarial osteoblasts were infected with lentivirus expressing either shGFP or shGATA4. Cells 
were then differentiated for two weeks and then treated with 10 nM E2 for 24 hours. Protein was 
obtained and immunoblots for ER, GATA4 and actin were performed. (C) RNA was obtained 
as in (A) and qPCR was performed with primers to FasL and normalized to actin mRNA. (D) 
RNA was obtained as in (A) and qPCR was performed with primers to Alkaline Phosphatase and 
normalized to actin mRNA. *=p value < 0.05; **= p value < .001. 
 
Fig. 2. GATA4 regulates differentiation and mineralization in vitro. (A) Primary calvarial 
osteoblasts were infected with lentivirus expressing an shRNA directed to GFP (shGFP) or to 
Gata4 (shGATA4). The following day the cells were placed in mineralization media and allowed 
to differentiate for 3, 7 or 14 days. Cells were then fixed and assayed for alkaline phosphatase. 
(B) Primary calvarial osteoblasts were infected with lentivirus expressing an shRNA directed to 
GFP (shGFP) or to Gata4 (shGATA4). The following day the cells were placed in mineralization 
m dia and allowed to differentiate for two weeks. Cells were then fixed and stained using 
alizarin red. Alizarin red was eluted and the mineral content was measured at an OD of 570. 
Silencing was performed in three wells and the average OD is displayed. (C-F) Calvarial 
osteoblasts were infected with lentivirus expressing either shGFP or shGATA4. Cells were then 
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differentiated for two weeks and RNA was obtained. qPCR was performed for the indicated 
genes and normalized to actin mRNA. *= p value < .05, **= p value < .001. 
Fig. 3. GATA4 regulates bone mineralization early in the differentiation process. (A) Bone 
marrow stromal cells were differentiated for 0, 1, 2 or 16 days. RNA was obtained and qPCR 
was performed for Gata4 and normalized to actin mRNA. Mammary gland (MG) RNA was also 
obtained for comparison. (B) Fat adventitial cells, fetal lung pericytes and fetal muscle pericytes 
were left undifferentiated or differentiated to mineralizing osteoblasts. RNA was obtained and 
qPCR was performed for Gata4 and normalized to actin mRNA. (C) Human fetal bone marrow 
CD146+ cells (pericytes) were cultured in osteoblast differentiation media for 3, 7, 10 and 14 
days. RNA was obtained and qPCR was performed for Gata4, Col1A1 and Alkaline phosphatase 
cDNA and normalized to actin mRNA. (D) Design of experiment for parts E-G. (E) Human fetal 
bone marrow CD146+ cells (pericytes) were cultured in osteoblast differentiation media for 3, 7, 
10 and 14 days. At the indicated times cells were fixed and assayed for alkaline phosphatase. (F) 
Pericytes were infected with lentivirus expressing shC or shGATA4 either “early” at day 0 or 
“late” at day 7. All cells were placed in mineralization media at day 1 and allowed to 
differentiate for two weeks. Cells were then fixed and stained using alizarin red. (G) Alizarin red 
from part (F) was eluted and the mineral content was measured at an OD of 570. Silencing was 
performed in three wells and the average OD is displayed. *=p value < 0.05 
 
Fig. 4. In situ analysis of Gata4 expression. Sagittal sections of E13.5, E14.5, E16.5 and E18.5 
wildtype FVB embryos were probed for Gata4 expression (brown) and counterstained with 
hematoxylin (blue). Arrows indicate Gata4 expression in bone. 
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Fig. 5. GATA4 cKO mice are not born at expected Mendelian ratios. (A) The recombination 
efficiency of Cre-mediated excision was measured by qPCR from cDNA from differentiated WT 
and cKO calvarial organ cultures. (B) Tail DNA was obtained from mice at E14.5, E16.5, E18.5, 
P0, P1 and P21. Genotyping was performed for the presence of Floxed Gata4 and for Cre 
recombinase. The percent of mice that were GATA4 Fl/Fl/Cre+ (% cKO) is graphed. *=p value 
< 0.05; **= p value < .001; ***= p value < .0001. (C) Photograph of representative WT and cKO 
mice at E18.5. (D) Photograph of representative WT and cKO mice at P1. (E) Weight, in grams, 
of newborn WT and cKO mice. 
 
Fig. 6. GATA4 cKO mice have skeletal defects. (A-D) Skeletal preparations of E18.5 WT (A, C) 
and cKO (B, D) mice. (A,B) Whole body. (C,D) Superior view of skull. Zy=zygomatic bone. 
Red arrow indicates decreased zygomatic bone size in cKO mice. Yellow arrows highlight a 
suture defect in the cKO skull. (E,F) MicroCT images of WT (E) and cKO (F) skulls. Arrow 
points to occipital bone. (G,H) H&E staining of sagittal sections of WT (G) and cKO (H) heads. 
Red line indicates thickness of skull bone. (I,J) Von Kossa staining of sagittal sections of WT (I) 
and cKO (J) heads. (K,L) Skeletal preparations of spine from WT (K) and cKO (L). (M) Total 
spine length of n=7 mice. *=p value < 0.05. (N,O) H&E staining of sagittal sections of WT (N) 
and cKO (O) vertebrae. Von Kossa staining of sagittal sections of WT (P) and cKO (Q) 
vertebrae. (R,S) Skeletal preparations of tibia and fibula from WT (R) and cKO (S). Green arrow 
indicates lack of fusion of tibia and fibula. (T,U) MicroCT images of WT (T) and ckO (U) tibia 
and fibula at their closest distance. (V, W)  H&E staining of sagittal sections of WT (V) and cKO 
(W) femurs. h.ch.=hypertrophic chondrocytes. Von Kossa staining of sagittal sections of WT (X) 
and cKO (Y) femurs. 
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Fig. 7. Comparison of trabecular bone structure in P0 WT and cKO mice assessed by microCT. 
(A, B) Representative microCT images of WT and cKO femurs. (C) Bone volume/total volume 
(BV/TV), (D) trabecular number (Tb.N.), (E) and trabecular thickness (Tb.Th.) were decreased 
in femurs of cKO mice. (F) There was no statistical increase in trabecular spacing (Tb.Sp.) in 
cKO mice. (G, H) Representative microCT images of WT and cKO L5 vertebrae. Arrows 
indicate defects in shape. (I) BV/TV, (J) Tb.N., (K) Tb.Th., and (L) Tb.Sp. of L5 vertebrae in 
WT and cKO L5 vertebrae. N=9; *=p value < 0.05 
 
Fig. 8. GATA4 regulates the TGF and BMP pathways in osteoblasts. (A) Calvarial osteoblasts 
were infected with lentivirus expressing either shGFP or shGATA4. Cells were then 
differentiated for two weeks and RNA was obtained. qPCR was performed for the indicated 
genes and normalized to actin mRNA. (B) Calvarial osteoblasts were infected with lentivirus 
expressing either shGFP or shGATA4. Cells were then differentiated for two weeks and then 
treated with E2 for 24 hours. Protein was obtained and immunoblots for pSMAD1/5/8, SMAD5, 
GATA4 and actin were performed. (C) RNA was obtained as in (A) and qPCR was performed 
for the indicated genes and normalized to actin mRNA. (D) Protein was obtained as in (B) and 
immunoblots for pSMAD3, pSMAD2, GATA4 and actin were performed. (E) IHC with an 
antibody to pSMAD1/5/8 was performed on femurs from P0 wildtype (Fl/Fl) and cKO (Fl/Fl; 
Cre+) mice. H.Ch.= hypertrophic chondrocytes. Tr= trabecular bone. (F) Immunofluorescence 
with an antibody to pSMAD1/5/8 was performed on femurs from P0 wildtype (Fl/Fl) and cKO 
(Fl/Fl; Cre+) mice. h.ch.= hypertrophic chondrocytes. Tr= trabecular bone. *=p value < 0.05. 
**= p value < .001. 
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